Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-08-08 00:00:00 ET · period of report 2025-08-06 · accession 0001415889-25-021346 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-08 | 2025-08-06 | KNSA | Paolini John F. | Chief MEDICAL Off | S - Sale+OE | $32.55 | -29.3K | 57.4K | -34% | -$954.5K |
| D | 2025-08-08 | 2025-08-06 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $3.80 | +29.3K | 86.7K | +51% | +$111.4K |
| D | 2025-08-08 | 2025-08-06 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $0.00 | -29.3K | 36.5K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-08-06 | S | D | 29,325 | $32.55 | 57,403 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.13 and $33.08. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 2 | Common | Class A Ordinary Share | 2025-08-06 | M | A | 29,325 | $3.80 | 86,728 | D | — | — | |
| 3 | Derivative | Share Option | 2025-08-06 | M | D | 29,325 | $0.00 | 36,542 | D | $3.80 · — to 2027-06-28 | 29,325 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |